查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2088647

CBD消費者保健市場：2026-2032年全球市場預測（按產品類型、劑型、頻譜類型、應用和最終用戶分類）

CBD Consumer Health Market by Product Type, Form, Spectrum Types, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，CBD 消費者保健市場將成長至 415.6 億美元，複合年成長率為 16.35%。

主要市場統計數據
基準年 2025 143.9億美元
預計年份：2026年 166.2億美元
預測年份 2032 415.6億美元
複合年成長率 (%) 16.35%

CBD消費健康市場正從高成長的健康產業轉向更標準化、以實證為基礎的消費者保健產業。大麻二酚（CBD）是一種從大麻或工業大麻中提取的非精神活性大麻素。世界衛生組織（WHO）報告稱，純CBD不具有濫用或成癮性，而美國食品藥物管理局（FDA）已批准精製CBD藥物用於治療某些罕見的癲癇症。這些已證實的事實持續影響消費者的信心、產品定位和監管力度。

消費者對非致幻性健康產品的需求推動了市場成長，這些產品包括精油、膠囊、外用製劑、食用產品、飲品和個人保健產品。然而，該品類的長期價值取決於品質保證、準確的標籤、污染物檢測、負責任的功效聲明以及市場合規性。將基於CBD的消費者保健創新與透明的採購流程、臨床級文件和數位化教育相結合的品牌，將能夠在競爭激烈的市場中脫穎而出。

CBD消費者健康領域的變革

監管、零售業重組以及消費者購買行為從追求新奇轉向信任，正在改變該行業的格局。在美國，2018年農業法案將大麻定義為“乾以重量為準中Delta-9-四氫大麻酚含量低於0.3%的大麻”，此後，源自大麻的CBD市場迅速擴張。然而，美國食品藥物管理局（FDA）對食品和膳食補充劑中CBD的監管仍然影響著銷售管道策略。在歐洲，CBD萃取物通常作為「新食品」進行評估，因此核准流程對於其商業化至關重要。

人工智慧對CBD產業消費者健康的累積影響

人工智慧 (AI) 正在 CBD 消費健康領域的整個價值鏈中發揮累積的作用。 AI 驅動的需求預測使品牌能夠調整庫存，以匹配暢銷產品形式（例如軟糖、酊劑、外用製劑和機能飲料），從而減少缺貨和產能過剩。此外，機器學習可用於分析來自種植和提取合作夥伴的測試結果、農藥篩檢、重金屬數據以及批次間一致性，從而支持供應商風險評估。

CBD消費者健康市場的關鍵區域洞察

北美憑藉其大規模的美國大麻供應基地、先進的D2C（直接面對消費者）管道以及廣泛的零售試驗，仍然是CBD消費健康領域最主要的地區。同時，加拿大聯邦監管的大麻體系為大麻素產品提供了一個系統性的國家框架。在拉丁美洲，市場正透過醫用大麻計畫、法院判決和關於大麻政策的辯論而發展，其中巴西和墨西哥尤其引人注目，因為它們擁有龐大的消費群體、可透過藥房購買到CBD產品以及不斷發展的醫療途徑。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

在東協地區，隨著健康理念的迅速普及，CBD在消費者保健市場的發展機會日益凸顯，但同時也受到嚴格的藥品法律和區域間不一致的大麻監管改革的限制。儘管泰國的政策調整已引起區域關注，但鄰近市場仍保持謹慎，需要仔細考慮執法問題。海灣合作理事會（GCC）地區擁有較高的購買力和成熟的保健零售市場，但其保守的藥品管理體制要求企業在進入CBD市場、產品分銷、標籤標註和數位推廣等方面都必須格外謹慎。

主要國家對CBD消費者健康的見解

美國是CBD消費保健領域最主要的市場，但企業需要應對大麻合法化與FDA對口服CBD標籤限制的差距。加拿大擁有完善的國家大麻法律規範，而墨西哥和巴西是重要的拉丁美洲市場，其合法化進程正在不斷發展，並且具有強勁的長期消費潛力。在歐洲，英國、德國、法國、義大利和西班牙是主要的需求中心，但CBD的相關法規因產品類型、THC耐受程度、新食品地位、化妝品用途以及當地執法情況而異。俄羅斯仍然是一個監管嚴格的市場，與西歐相比，其在CBD消費保健領域的機會有限。

為CBD消費者健康領域的領導者提供實用建議。

行業領導企業應在產品上市前優先考慮“合規設計”，首先要確保產品分類、THC容許限值、成分核准、標籤審核以及符合特定市場的廣告法規。每批產品都必須附上第三方分析證書，涵蓋大麻素含量、殘留溶劑、農藥、重金屬、微生物污染以及THC合規性。

調查方法

本執行摘要基於二手調查方法，參考了公開的監管、科學和行業資訊來源。主要資訊來源包括美國食品藥物管理局 (FDA)、美國農業部 (USDA)、加拿大衛生署、歐盟委員會、世界衛生組織 (WHO) 以及各國大麻和藥品監管機構等政府和政府間組織的文件。分析還考慮了公開的政策框架、產品安全預期、市場准入要求以及零售和電子商務趨勢。

結論

CBD消費保健市場正邁入一個更規範化的階段，信任、安全性和合規性將決定競爭優勢。儘管消費者興趣依然濃厚，但那些將透明的採購流程、嚴格的檢測、負責任的標籤標註、符合市場規範並輔以清晰易懂的教育宣傳活動的品牌，將引領行業發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：CBD消費者保健市場：依產品類型分類

  • 膠囊
    • 軟凝膠
    • 藥片
  • 食用產品
    • 軟糖
    • 巧克力
    • 糖果
    • 小吃
  • 油
  • 外部產品
    • 藥膏/軟膏
    • 乳霜和乳液
    • 修補
  • 飲料
    • 水
    • 茶
    • 咖啡
    • 能量飲料

第8章：CBD消費者保健市場：依形式分類

  • 液體
  • 固體的

第9章：CBD消費者保健市場：依頻譜類型分類

  • 全光譜CBD
  • 頻譜CBD

第10章：CBD消費者保健市場：依應用領域分類

  • 心理健康
    • 焦慮
    • 壓力
    • 憂鬱症
  • 神經病變
    • 癲癇
    • 對帕金森氏症的支持
  • 疼痛管理
    • 慢性疼痛
    • 關節炎引起的疼痛
    • 肌肉酸痛
  • 護膚
    • 粉刺
    • 濕疹
    • 銀屑病
  • 睡眠障礙

第11章：CBD消費者保健市場：以最終用戶分類

  • 人類
    • 成人
    • 老年人
  • 動物
    • 狗
    • 貓

第12章：CBD消費者保健市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：CBD消費者保健市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：CBD消費者保健市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Ananta Hemp Works
  • Awshad
  • Bluebird Botanicals
  • Bombay Hemp Company Private Limited
  • Cannarma
  • CBD American Shaman, LLC
  • cbdMD, Inc.
  • Charlotte's Web Holdings, Inc.
  • Cornbread Hemp
  • CV Sciences, Inc.
  • Elixinol Wellness Ltd.
  • Endoca BV
  • Fab Nutrition, LLC
  • Folium Biosciences
  • Green Roads LLC
  • HempCann Solutions Private Limited
  • India Hemp Organics
  • Joy Organics, LLC
  • Kazmira LLC
  • Lazarus Naturals
  • Medical Marijuana, Inc.
  • Medterra CBD, LLC
  • NuLeaf Naturals, LLC
  • PharmaHemp doo
  • Pure Hemp Botanicals
Product Code: MRR-A339DAEFA242

The CBD Consumer Health Market is projected to grow by USD 41.56 billion at a CAGR of 16.35% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.39 billion
Estimated Year [2026] USD 16.62 billion
Forecast Year [2032] USD 41.56 billion
CAGR (%) 16.35%

The CBD consumer health market is evolving from a high-growth wellness category into a more regulated, evidence-led segment of consumer healthcare. Cannabidiol, or CBD, is a non-intoxicating cannabinoid derived from cannabis or hemp; the World Health Organization has reported that pure CBD does not appear to have abuse or dependence potential, while the U.S. FDA has approved a purified CBD medicine for specific rare seizure disorders. These verified facts continue to shape consumer trust, product positioning, and regulatory scrutiny.

Demand is being driven by consumers seeking non-intoxicating wellness formats across oils, capsules, topicals, edibles, beverages, and personal care products. However, the category's long-term value depends on quality assurance, accurate labeling, contaminant testing, responsible claims, and market-specific compliance. Brands that combine CBD consumer health innovation with transparent sourcing, clinical-grade documentation, and digital education are best positioned to compete in a crowded marketplace.

Transformative Shifts in the CBD Consumer Health Landscape

The landscape is being reshaped by regulation, retail consolidation, and a clear shift from novelty purchasing to trust-based purchasing. In the United States, hemp-derived CBD expanded after the 2018 Farm Bill defined hemp as cannabis containing not more than 0.3% delta-9 THC on a dry-weight basis, but FDA restrictions on CBD in foods and dietary supplements continue to influence channel strategy. In Europe, CBD extracts are generally assessed through the Novel Food framework, making authorization pathways central to commercialization.

Consumer expectations are also changing. Shoppers increasingly compare certificates of analysis, THC content, extraction methods, ingredient transparency, and sustainability claims before purchase. This is pushing CBD consumer health companies toward pharmaceutical-style quality systems, validated supply chains, and stronger post-market monitoring. At the same time, mainstream retailers and digital marketplaces are tightening standards, favoring compliant brands with defensible claims over unverified wellness messaging.

Cumulative Impact of Artificial Intelligence on CBD Consumer Health

Artificial intelligence is becoming a cumulative force across the CBD consumer health value chain. AI-enabled demand forecasting helps brands align inventory with fast-moving formats such as gummies, tinctures, topicals, and functional beverages, reducing stockouts and overproduction. Machine learning can also support supplier risk scoring by analyzing laboratory results, pesticide screenings, heavy-metal data, and batch consistency across cultivation and extraction partners.

AI is particularly valuable in regulatory intelligence and consumer engagement. Natural language processing can monitor changes in FDA communications, European Novel Food decisions, Health Canada rules, and advertising standards, helping teams update claims and packaging faster. In eCommerce, AI-driven personalization can improve product education, but responsible governance is essential: brands must avoid disease-treatment claims for non-approved products and ensure that chatbot responses, recommendation engines, and influencer content remain compliant.

Key Regional Insights for CBD Consumer Health

North America remains the most visible CBD consumer health region because of the United States' large hemp supply base, advanced direct-to-consumer channels, and extensive retail experimentation, while Canada's federally regulated cannabis system provides a structured national framework for cannabinoid products. Latin America is developing through medical cannabis programs, court decisions, and hemp policy discussions, with Brazil and Mexico drawing attention for consumer scale, pharmacy-based access, and evolving healthcare pathways.

Europe is defined by a more cautious and documentation-heavy approach, especially through Novel Food assessments, cosmetics requirements, and national enforcement differences across the European Union and the United Kingdom. Asia-Pacific presents long-term potential but fragmented regulation; Japan has permitted certain CBD products under strict THC controls, Australia manages access through therapeutic goods pathways, and China is important in hemp cultivation and ingredient supply despite tighter domestic cannabis controls. The Middle East and Africa are earlier-stage markets, with GCC jurisdictions taking conservative positions and selected African economies exploring cannabis cultivation, export, or medical frameworks.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, CBD consumer health opportunities are shaped by rapid wellness adoption but constrained by strict narcotics laws and uneven cannabis reforms; Thailand's policy changes created regional attention, while neighboring markets remain cautious and enforcement-sensitive. The GCC is characterized by high purchasing power and sophisticated healthcare retail, yet conservative drug-control regimes require extreme caution for CBD market entry, product movement, labeling, and digital promotion.

The European Union is a key regulatory benchmark because Novel Food review, cosmetics rules, and THC thresholds influence global compliance strategies. BRICS economies represent a mixed opportunity set: China and India offer scale and botanical supply-chain relevance, Brazil is advancing cannabis-based health access, Russia remains restrictive, and South Africa has become an important African policy reference point. G7 markets are central to premium CBD consumer health demand, research standards, and multinational retail entry, while NATO members overlap heavily with North American and European jurisdictions where traceability, safety, and advertising compliance are strategic requirements.

Key Country Insights for CBD Consumer Health

The United States leads CBD consumer health visibility, but companies must navigate the gap between hemp legality and FDA limits on ingestible CBD claims. Canada offers a national cannabis framework, while Mexico and Brazil are important Latin American markets with evolving legal access and strong long-term consumer potential. In Europe, the United Kingdom, Germany, France, Italy, and Spain are important demand centers, though CBD rules differ by product type, THC limit, Novel Food status, cosmetics use, and local enforcement. Russia remains a restrictive market with limited CBD consumer health opportunity compared with Western Europe.

In Asia-Pacific, China is significant for hemp cultivation and ingredient processing but highly restrictive on domestic cannabis consumer products. India has a long history of hemp and cannabis-related traditional use, yet modern CBD commercialization is highly dependent on state and national controls. Japan permits carefully controlled CBD products with strict THC expectations, Australia regulates cannabinoid access through therapeutic goods channels, and South Korea maintains tight cannabis controls with limited medical exceptions. These country-level differences make localized compliance, labeling, testing, claims substantiation, and distribution strategy essential.

Actionable Recommendations for CBD Consumer Health Leaders

Industry leaders should prioritize compliance-by-design, beginning with product classification, THC limits, ingredient approvals, claims review, and market-by-market advertising controls before launch. Every batch should be supported by third-party certificates of analysis covering cannabinoid potency, residual solvents, pesticides, heavy metals, microbial contamination, and THC compliance.

Companies should invest in differentiated, evidence-aligned formats rather than broad wellness claims. Topicals, cosmetics, sleep-adjacent products, functional formulations, and pharmacist-supported education can help build trust when claims are conservative and substantiated. Leaders should also use AI for regulatory monitoring, demand forecasting, and quality analytics while maintaining human review for claims, labeling, and consumer safety communications.

Research Methodology

This executive summary is developed using a secondary research methodology grounded in publicly available regulatory, scientific, and industry sources. Core inputs include government and intergovernmental materials from agencies such as the U.S. FDA, USDA, Health Canada, the European Commission, the World Health Organization, and national cannabis or therapeutic goods authorities. The analysis also considers published policy frameworks, product safety expectations, market-entry requirements, and observed retail and eCommerce trends.

Insights were synthesized through cross-regional comparison, regulatory triangulation, and qualitative assessment of supply-chain, consumer, and technology drivers. Emphasis was placed on verified facts, including legal definitions, approval pathways, known regulatory constraints, and established safety considerations. Market interpretation avoids unsupported medical claims and focuses on commercially relevant, evidence-led implications for CBD consumer health stakeholders.

Conclusion

The CBD consumer health market is moving toward a more disciplined phase in which trust, safety, and regulatory readiness determine competitive advantage. Consumer interest remains strong, but the leading brands will be those that combine transparent sourcing, rigorous testing, responsible claims, and market-specific compliance with accessible education.

Artificial intelligence, digital commerce, and global wellness demand will continue to influence the category, but they will not replace the need for scientific credibility and regulatory discipline. Companies that build evidence-led portfolios and adaptable compliance systems can capture long-term value as CBD consumer health matures across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. CBD Consumer Health Market, by Product Type

  • 7.1. Capsules
    • 7.1.1. Softgels
    • 7.1.2. Tablets
  • 7.2. Edibles
    • 7.2.1. Gummies
    • 7.2.2. Chocolates
    • 7.2.3. Candies
    • 7.2.4. Snacks
  • 7.3. Oils
  • 7.4. Topicals
    • 7.4.1. Balms & Salves
    • 7.4.2. Creams & Lotions
    • 7.4.3. Patches
  • 7.5. Beverages
    • 7.5.1. Water
    • 7.5.2. Tea
    • 7.5.3. Coffee
    • 7.5.4. Energy Drinks

8. CBD Consumer Health Market, by Form

  • 8.1. Liquid
  • 8.2. Solid

9. CBD Consumer Health Market, by Spectrum Types

  • 9.1. Full Spectrum CBD
  • 9.2. Broad Spectrum CBD

10. CBD Consumer Health Market, by Application

  • 10.1. Mental Health
    • 10.1.1. Anxiety
    • 10.1.2. Stress
    • 10.1.3. Depression
  • 10.2. Neurological Disorders
    • 10.2.1. Epilepsy
    • 10.2.2. Parkinson's Support
  • 10.3. Pain Management
    • 10.3.1. Chronic Pain
    • 10.3.2. Arthritis Pain
    • 10.3.3. Muscle Pain
  • 10.4. Skin Care
    • 10.4.1. Acne
    • 10.4.2. Eczema
    • 10.4.3. Psoriasis
  • 10.5. Sleep Disorders

11. CBD Consumer Health Market, by End User

  • 11.1. Humans
    • 11.1.1. Adults
    • 11.1.2. Elderly
  • 11.2. Animals
    • 11.2.1. Dogs
    • 11.2.2. Cats

12. CBD Consumer Health Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. CBD Consumer Health Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. CBD Consumer Health Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Ananta Hemp Works
  • 16.2. Awshad
  • 16.3. Bluebird Botanicals
  • 16.4. Bombay Hemp Company Private Limited
  • 16.5. Cannarma
  • 16.6. CBD American Shaman, LLC
  • 16.7. cbdMD, Inc.
  • 16.8. Charlotte's Web Holdings, Inc.
  • 16.9. Cornbread Hemp
  • 16.10. CV Sciences, Inc.
  • 16.11. Elixinol Wellness Ltd.
  • 16.12. Endoca BV
  • 16.13. Fab Nutrition, LLC
  • 16.14. Folium Biosciences
  • 16.15. Green Roads LLC
  • 16.16. HempCann Solutions Private Limited
  • 16.17. India Hemp Organics
  • 16.18. Joy Organics, LLC
  • 16.19. Kazmira LLC
  • 16.20. Lazarus Naturals
  • 16.21. Medical Marijuana, Inc.
  • 16.22. Medterra CBD, LLC
  • 16.23. NuLeaf Naturals, LLC
  • 16.24. PharmaHemp d.o.o.
  • 16.25. Pure Hemp Botanicals

LIST OF FIGURES

  • FIGURE 1. GLOBAL CBD CONSUMER HEALTH MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CBD CONSUMER HEALTH MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CBD CONSUMER HEALTH MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CBD CONSUMER HEALTH MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CBD CONSUMER HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CBD CONSUMER HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SOFTGELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SOFTGELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SOFTGELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EDIBLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EDIBLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EDIBLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GUMMIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GUMMIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GUMMIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CHOCOLATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CHOCOLATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CHOCOLATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CANDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CANDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CANDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SNACKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SNACKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SNACKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TOPICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TOPICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TOPICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BALMS & SALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BALMS & SALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BALMS & SALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BEVERAGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BEVERAGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BEVERAGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COFFEE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COFFEE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COFFEE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENERGY DRINKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENERGY DRINKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENERGY DRINKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LIQUID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SOLID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SOLID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SOLID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FULL SPECTRUM CBD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FULL SPECTRUM CBD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FULL SPECTRUM CBD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BROAD SPECTRUM CBD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BROAD SPECTRUM CBD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BROAD SPECTRUM CBD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MENTAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MENTAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MENTAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANXIETY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANXIETY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANXIETY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STRESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STRESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STRESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PARKINSON'S SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PARKINSON'S SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PARKINSON'S SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTHRITIS PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ARTHRITIS PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTHRITIS PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MUSCLE PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MUSCLE PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MUSCLE PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SKIN CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SKIN CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SKIN CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ACNE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ACNE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ACNE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ECZEMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ECZEMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ECZEMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PSORIASIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PSORIASIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PSORIASIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SLEEP DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SLEEP DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SLEEP DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HUMANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HUMANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HUMANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ADULTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 253. GCC CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 256. GCC CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 257. GCC CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 260. GCC CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 261. GCC CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. GCC CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 263. GCC CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 265. GCC CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 266. GCC CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GCC CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. G7 CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 304. G7 CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 305. G7 CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 306. G7 CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 307. G7 CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 308. G7 CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 309. G7 CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 310. G7 CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 311. G7 CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 312. G7 CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 313. G7 CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 314. G7 CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. G7 CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 316. G7 CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. NATO CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. NATO CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 320. NATO CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 321. NATO CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 322. NATO CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 323. NATO CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 324. NATO CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 325. NATO CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. NATO CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 327. NATO CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 328. NATO CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 329. NATO CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 330. NATO CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 331. NATO CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 332. NATO CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 333. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 350. CANADA CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 351. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 353. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 354. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 355. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 356. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 357. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 358. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 359. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 360. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 361. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 362. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 363. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 364. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 365. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 366. MEXICO CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 367. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 368. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 369. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
  • TABLE 370. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
  • TABLE 371. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 372. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 373. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY SPECTRUM TYPES, 2018-2032 (USD MILLION)
  • TABLE 374. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 375. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY MENTAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 376. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 377. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 378. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 379. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 380. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY HUMANS, 2018-2032 (USD MILLION)
  • TABLE 381. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 382. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 383. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-